CXCR4 and cancer: Repetitive i.t. administration of CXCR4 siRNA remarkably suppressed TCI-induced cancer pain behaviors (mechanical allodynia, thermal hyperalgesia, spontaneous flinching and loss of limb use), which is consistent with our previous findings11.